TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (Nasdaq:CGEN) today announced the development and validation of its new Viral Peptides Discovery Platform designed to identify peptides from viral genomes for potential human therapeutic use against inflammatory and immune related diseases.
